Bringing the fundamentals into focus…
Back to Akebia Therapeutics, Inc.
How Akebia Therapeutics, Inc. stacks up
AKBA · against 238 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #152 of 239 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score88 peers with a valuation score of 0–9, including AKBA · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -14.7% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -1.8% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 96% of peers. Free cash flow yield: 20.0% vs peer median 0.0%
Metric by metric
Position: dot = AKBA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AKBA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 223 reported | -17.9% | -2.9% | 33% | 30% | |
| EBITDA yieldHigher is better · 245 reported | -1.8% | 1.3% | 43% | 50% | |
| Free cash flow yieldHigher is better · 142 reported | 14.6% | -12.4% | 95% | 20% | |
| Book yieldHigher is better · 227 reported | 12.7% | 61.3% | 15% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around AKBA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 152 | 13.0B TWD (≈$402M) | 8 | 49 | |
| 152 | 1.4B MYR (≈$309M) | 8 | 31 | |
| 152 | 243M USD | 8 | 27 | |
| 152 | 198M USD | 8 | 10 | |
| 152 | 201M USD | 8 | 24 | |
| 152 | 387M USD | 8 | 49 | |
| 152 | 397M USD | 8 | 37 | |
| 152 | 271M USD | 8 | 14 | |
| 152 | 115M USD | 8 | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score